Physician profile
Meaghan Tucker
NPI 1326712373
$2,444.61
in general payments reported to CMS, 2019-2025
16 companies · $772 in 2025
The $772 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $765 · 2023: $521 · 2024: $387 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.93 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $903.94 | 2022-2025 | Lifevest |
| Atricure, INC. | $696.28 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $387.98 | 2022-2025 | Micra, Affera Mapping System, Mycarelink |
| Alnylam Pharmaceuticals INC. | $71.73 | 2022 | |
| Ebr Systems, INC. | $66.10 | 2025 | |
| Cvrx, INC. | $57.48 | 2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $51.91 | 2022-2023 | Farxiga |
| Kestra Medical Technology Services, INC. | $38.26 | 2022-2023 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $34.55 | 2022-2023 | |
| Vital Connect, INC | $25.78 | 2025 | Vitalpatch Rtm |
| Esperion Therapeutics, INC. | $24.21 | 2023 | Nexletol |
| Convatec INC. | $20.95 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.99 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.63 | 2022 | |
| Biosense Webster, INC. | $14.96 | 2023 | Carto 3, Octaray Mapping Catheter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meaghan Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.